Bioinformatics & Multi-Omics
Your data is not the bottleneck. Interpretation is.
USD 18–70K per dataset · 4–10 weeks · Report, figures, reproducible pipeline and an interpretation session
At a glance
- Price band
- USD 18–70K per dataset
- Duration
- 4–10 weeks
- Deliverable
- Report + pipeline
- Included
- Interpretation session
Indicative list price. Final scope and price confirmed in the proposal.
Talk to a scientistThe problem
Why teams buy this
Institutions generate more sequencing and omics data than they can analyse. Datasets sit unused, grant deliverables slip, and the postdoc who knew the pipeline has left.
What you get
Deliverables, not activity
- An analysis report with publication-quality figures
- A reproducible pipeline with the full parameter record - you can run it again without us
- The processed data package in standard formats
- An interpretation session with your research team, not just a document
Who this is for
Academic medical centres · universities · biotech without internal bioinformatics · hospital research units · government research programmes.
Proof
Representative result
Transcriptomic and proteomic data integrated across 240 tumour samples to define three molecular subtypes for a cancer-centre cohort study.
Representative programme - illustrates typical scope and outcomes; not an individual client account. Client-specific references are available on request under confidentiality.
Questions we get asked
The awkward ones, answered
Can you work within our grant budget and timeline?
Usually. Tell us both at the consultation and we will structure around them.
Will you co-author?
Where we have made a genuine scientific contribution and you want us to, yes.
Enterprise AI for Life Sciences
Ready to Advance Your Drug Discovery Pipeline?
Partner with Prognica Labs to leverage enterprise-grade AI, computational chemistry, and molecular simulation technologies that accelerate discovery, reduce development risk, and improve R&D productivity.
From biotech startups to global pharmaceutical organizations, we help research teams make faster, evidence-driven decisions across every stage of early drug discovery.